First Molecular Detection and Epidemiological Analysis of Equine Influenza Virus in Two Regions of Colombia, 2020–2023
Author:
Gonzalez-Obando Juliana12, Zuluaga-Cabrera Angélica3ORCID, Moreno Isabel4, Úsuga Jaime4ORCID, Ciuderis Karl4, Forero Jorge E.5ORCID, Diaz Andrés6, Rojas-Arbeláez Carlos2, Hernández-Ortiz Juan P.4ORCID, Ruiz-Saenz Julian1ORCID
Affiliation:
1. Grupo de Investigación en Ciencias Animales—GRICA, Facultad de Medicina Veterinaria y Zootecnia, Universidad Cooperativa de Colombia, Bucaramanga 680002, Colombia 2. Grupo de Epidemiología, Universidad de Antioquia, Medellín 050010, Colombia 3. Grupo de Investigación GISCA, Facultad de Medicina Veterinaria y Zootecnia, Fundación Universitaria Vision de las Américas, Medellín 050031, Colombia 4. GHI One Health Colombia, Universidad Nacional de Colombia, Medellín 050036, Colombia 5. Grupo de Investigación en Microbiología Ambiental, Escuela de Microbiología, Universidad de Antioquia, Medellín 050010, Colombia 6. Pig Improvement Company Hendersonville, Hendersonville, TN 37075, USA
Abstract
Equine influenza is a viral disease caused by the equine influenza virus (EIV), and according to the WOAH, it is mandatory to report these infections. In Latin America and Colombia, EIV risk factors have not been analyzed. The objective of this research is to perform an epidemiological and molecular analysis of the EIV in horses with respiratory symptoms from 2020 to 2023 in Colombia. Molecular EIV detection was performed using RT–qPCR and nanopore sequencing. A risk analysis was also performed via the GEE method. A total of 188 equines with EIV respiratory symptoms were recruited. The positivity rate was 33.5%. The descriptive analysis showed that only 12.8% of the horses were vaccinated, and measures such as the quarantine and isolation of symptomatic animals accounted for 91.5% and 88.8%, respectively. The variables associated with the EIV were the non-isolation of positive individuals (OR = 8.16, 95% CI (1.52–43.67), p = 0.014) and sharing space with poultry (OR = 2.16, 95% CI (1.09–4.26), p = 0.027). In conclusion, this is the first EIV investigation in symptomatic horses in Colombia, highlighting the presence of the virus in the country and the need to improve preventive and control measures.
Reference55 articles.
1. Zhu, H., Damdinjav, B., Gonzalez, G., Patrono, L.V., Ramirez-Mendoza, H., Amat, J.A.R., Crispell, J., Parr, Y.A., Hammond, T.-a., and Shiilegdamba, E. (2019). Absence of adaptive evolution is the main barrier against influenza emergence in horses in Asia despite frequent virus interspecies transmission from wild birds. PLoS Pathog., 15. 2. Singh, R.K., Dhama, K., Karthik, K., Khandia, R., Munjal, A., Khurana, S.K., Chakraborty, S., Malik, Y.S., Virmani, N., and Singh, R. (2018). A Comprehensive Review on Equine Influenza Virus: Etiology, Epidemiology, Pathobiology, Advances in Developing Diagnostics, Vaccines, and Control Strategies. Front. Microbiol., 9. 3. WOAH (2019). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, World Organisation for Animal Health. 4. Virus taxonomy and the role of the International Committee on Taxonomy of Viruses (ICTV);Siddell;J. Gen. Virol.,2023 5. Equine influenza—A global perspective;Cullinane;Vet. Microbiol.,2013
|
|